乙酰半胱氨酸
细胞凋亡
病理生理学
炎症
心肌纤维化
纤维化
心肌病
卡尔帕因
体内
内分泌学
内科学
心脏纤维化
化学
医学
癌症研究
药理学
心力衰竭
生物
抗氧化剂
生物化学
酶
生物技术
作者
Mengni Bao,Xiumeng Hua,Han Mo,Zhe Sun,Bo Xu,Xiao Chen,Mengda Xu,Xinjie Xu,Jiangping Song
出处
期刊:Biomolecules
[MDPI AG]
日期:2022-08-29
卷期号:12 (9): 1195-1195
被引量:2
摘要
Hyperthyroidism is common and can induce cardiomyopathy, but there is no effective therapeutic strategy. The purpose of this study was to investigate the molecular mechanism of hyperthyroidism-induced cardiomyopathy (HTC) and the effect of N-acetylcysteine (NAC), an ROS inhibitor, on the pathophysiology of HTC in vivo and in vitro. Compared with those in the control groups in vivo and in vitro, TT3 and TT4 were significantly increased, the structure of myocardial cells was enlarged and disordered, and interstitial fibrosis and the apoptosis of myocardial cells were markedly increased in the L-Thy group. The ROS and inflammatory response were increased in the hyperthyroidism group. In the NAC group, the contents of TT3 and TT4 were decreased, the myocardial cell structure was slightly disturbed, fibrosis and apoptosis were significantly reduced, and the ROS level and inflammatory response were significantly reduced. Interestingly, L-Thy decreased the viability of fibroblasts and H9c2 cells, suggesting that L-Thy-induced fibrosis was not caused by the proliferation of fibroblasts. The molecular mechanism of HTC could be explained by the fact that L-Thy could cause cardiac hypertrophy, inflammation, and fibrosis by regulating the Ca2+/calpain/Rcan1-dependent signalling pathway, the Ca2+/Rcan1/NF-κB/p65-dependent signalling pathway, and the Ca2+/ROS/Bcl-2/caspase-3-dependent signalling pathway. In conclusion, NAC can alleviate the pathophysiology of hyperthyroidism-induced cardiomyopathy, probably by regulating the ROS/Ca2+-dependent pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI